Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982794priorityCriticalpatent/ECSP982794A/en
Publication of ECSP982794ApublicationCriticalpatent/ECSP982794A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe una composición para dispersión molecular. La dispersión molecular comprende a un compuesto de la fórmula: (gráfico), molecularmente disperso en una matriz polimérica. También se describen las formas de dosificación sólidas por ejemplo, tabletas y cápsulas que contienen a estas dispersiones moleculares.A composition for molecular dispersion is described. The molecular dispersion comprises a compound of the formula: (graph), molecularly dispersed in a polymer matrix. Solid dosage forms are also described eg tablets and capsules containing these molecular dispersions.
ECSP9827941998-12-171998-12-17
COMPOSITION FOR MOLECULAR DISPERSION WITH INCREASED BIOAVAILABILITY
ECSP982794A
(en)
Dry solid composition for drug release, process for drug preparation, use of a large number of small spheres that contain a polymeric matrix composed of a polyethylene glycol or a mixture of polyethylene glycols
BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES